(IONS) Ionis Pharmaceuticals - Performance -15.5% in 12m
IONS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-42.03%
#58 in Peer-Group
Rel. Strength
26.56%
#5455 in Stock-Universe
Total Return 12m
-15.52%
#75 in Peer-Group
Total Return 5y
-33.00%
#45 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 90.9 |
| High / Low | USD |
|---|---|
| 52 Week High | 51.86 USD |
| 52 Week Low | 25.51 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 95.86 |
| Buy/Sell Signal +-5 | -0.18 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: IONS (-15.5%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.31% | 66.4% | 81.3% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.3% | -10.9% | 137% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-2.26% | -8.02% | 39.9% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
2.47% | 33.7% | 4.38% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
12.2% | 64.2% | 3.4% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
1.42% | -10.5% | -0.06% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| PTCT NASDAQ PTC Therapeutics |
1.94% | 59.9% | -1.58% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.88% | 35.5% | 16% | 28.9 | 15.1 | 0.63 | -62.1% | -19.3% |
Performance Comparison: IONS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for IONS
| Total Return (including Dividends) | IONS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 18.95% | 3.18% | 4.52% |
| 3 Months | 31.92% | 2.36% | 10.25% |
| 12 Months | -15.52% | -10.75% | 14.16% |
| 5 Years | -33.00% | -24.51% | 116.91% |
| Trend Score (consistency of price movement) | IONS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 92% | 30.9% | 79.1% |
| 3 Months | 94.2% | 63.2% | 91.7% |
| 12 Months | -79.1% | -83.8% | 44% |
| 5 Years | -28% | -52.9% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th83.50 | 15.28% | 13.80% |
| 3 Month | %th83.00 | 28.87% | 19.65% |
| 12 Month | %th63.00 | -5.34% | -26.00% |
| 5 Years | %th78.50 | -11.24% | -69.11% |
FAQs
Does Ionis Pharmaceuticals (IONS) outperform the market?
No,
over the last 12 months IONS made -15.52%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.75%.
Over the last 3 months IONS made 31.92%, while XBI made 2.36%.
Performance Comparison IONS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
IONS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.2% | 14.4% | 8.8% | -30% |
| US NASDAQ 100 | QQQ | 2.6% | 13.4% | 7.4% | -30% |
| German DAX 40 | DAX | 2.4% | 18.6% | -6.4% | -46% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.9% | 16.4% | 12.8% | -32% |
| Hongkong Hang Seng | HSI | 2.9% | 12.1% | -8.4% | -51% |
| India NIFTY 50 | INDA | 2.8% | 16.6% | 7.9% | -16% |
| Brasil Bovespa | EWZ | 3.9% | 15.5% | -12.8% | -26% |
IONS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2% | 12.1% | 2.5% | -43% |
| Consumer Discretionary | XLY | 3.7% | 17.1% | 16.8% | -36% |
| Consumer Staples | XLP | 6.7% | 20.2% | 9.9% | -24% |
| Energy | XLE | 6.5% | 14.4% | 11.5% | -12% |
| Financial | XLF | 3.5% | 16.5% | 5.6% | -43% |
| Health Care | XLV | 4.3% | 17.3% | 15.5% | -10% |
| Industrial | XLI | 3.6% | 15.8% | 2% | -39% |
| Materials | XLB | 4.6% | 16.6% | 8.1% | -19% |
| Real Estate | XLRE | 7.9% | 19.4% | 10.5% | -27% |
| Technology | XLK | 2.4% | 10.5% | 6.7% | -26% |
| Utilities | XLU | 5.5% | 18% | 5.1% | -39% |
| Aerospace & Defense | XAR | 1.3% | 9.3% | -12.3% | -67% |
| Biotech | XBI | 4.8% | 15.8% | 21.6% | -5% |
| Homebuilder | XHB | 4.6% | 15.1% | 19.3% | -16% |
| Retail | XRT | 5.4% | 16.8% | 16.2% | -22% |
IONS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 9.8% | 9.89% | 16.0% | -5% |
| Natural Gas | UNG | 7.4% | 15.5% | 22.2% | -15% |
| Gold | GLD | 8.8% | 20.4% | -11.2% | -55% |
| Silver | SLV | 6.7% | 11.3% | -9.5% | -37% |
| Copper | CPER | 2.3% | 10.3% | -9.6% | -31% |
IONS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 4.9% | 17.1% | 12.7% | -17% |
| iShares High Yield Corp. Bond | HYG | 5.2% | 17.4% | 9.4% | -26% |